Phaseline

Companies › Serum Life Science Europe

Serum Life Science Europe: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 2; Other; next expected readout Jun 2028.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
wSp vaccine
Whole-cell inactivated pneumococcal vaccine to prevent nasopharyngeal colonization by Stre
–Phase 2Acute Otitis Media (AOM)Jun 2028

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07216430wSp vaccinePhase 2Acute Otitis Media (AOM)OtherJun 2028

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Distribuidora Biolife SA de CV Circul'Egg Intervene Immune Biosolution Photozig

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.